TickerFactsScreenerDevelopers

Allogene Therapeutics, Inc. (ALLO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $92.43M2019: $175.13M2020: $183.35M2021: $173.31M2022: $61.90M2023: $83.16M2024: $75.22M2025: $51.69M$51.69M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$51.69M-31.3%
2024$75.22M-9.5%
2023$83.16M+34.3%
2022$61.90M-64.3%
2021$173.31M-5.5%
2020$183.35M+4.7%
2019$175.13M+89.5%
2018$92.43M—